Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
Maria Grazia Rumi(University of Milan), Massimo Colombo(University of Milan), Antonio Russo(Ospedale San Carlo), Roberta D’Ambrosio(University of Southern California), Alessio Aghemo, E. Del Ninno(University of Milan), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Gian Maria Prati(University of Milan), Maria Francesca Donato(University of Milan)
Cited by 199
Related Papers
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|392